Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI

Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI

Treatment of atherosclerotic disease often focuses on reducing plasma LDL-cholesterol or increasing plasma HDL-cholesterol. We examined in vitro the effects on HDL receptor [scavenger receptor class B type I (SR-BI)] activity of three classes of clinical and experimental plasma HDL-cholesterol-eleva...

Full description

Bibliographic Details
Main Authors: Thomas J.F. Nieland, Jared T. Shaw, Firoz A. Jaipuri, Zoltan Maliga, Jay L. Duffner, Angela N. Koehler, Monty Krieger
Format: Article
Language:English
Published: Elsevier 2007-08-01
Series:Journal of Lipid Research
Subjects:
niacin
fibrates
HDL376
lipoprotein metabolism
fenofibrate
structure-activity relationship
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520425180

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520425180

Similar Items